'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma
- PMID: 29022836
- DOI: 10.1080/10428194.2017.1387911
'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma
Comment in
-
Pomalidomide - Author Reply.Leuk Lymphoma. 2019 Apr;60(4):1105. doi: 10.1080/10428194.2018.1516884. Epub 2018 Oct 2. Leuk Lymphoma. 2019. PMID: 30277106 No abstract available.
-
Real world experience with "generic" pomalidomide in relapsed refractory multiple myeloma.Leuk Lymphoma. 2019 Apr;60(4):1102-1104. doi: 10.1080/10428194.2018.1508675. Epub 2018 Oct 15. Leuk Lymphoma. 2019. PMID: 30322320 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical